Ping An Biomedical Co., Ltd.
Ping An Biomedical Co., Ltd. is a Hong Kong-based company with a U.S. listing that operates across healthcare, biomedical technology, and related commercial channels. Its reported activities also include one-stop supply chain management services for the apparel industry, indicating a business structure that combines consumer-facing health products, service channels, and trade/SCM capabilities.
Fiscal year 2025 · change from previous year
Development 2023–2025
Business
Share of revenueBiotechnology and biomedical offerings developed or sourced for health-related use.
Consumer health and wellness products sold through service and channel partners.
Services that expand distribution, customer access, and end-market conversion.
R&D-related and technical support activities tied to product development.
Supply chain management and related services for apparel industry customers.
Customers
The company appears to sell into health and wellness channels, including service providers that can help convert products into end-consumer use. It also serves partners that need biotechnology products, technical support, and commercialization assistance, while maintaining a separate supply-chain service relationship in apparel. The reported cooperation model suggests customers include channel partners, health-service operators, and enterprise clients seeking outsourced sourcing or SCM support.
Buy products and channel support to reach end consumers through wellness service settings.
Use the company's products and partner-enabled channels to deliver customer-facing wellness services.
Work with the company on R&D, technical support, and product rollout into market.
Purchase supply-chain management services tied to apparel sourcing and logistics.
Strategy
The company is focused on turning biotechnology and health-related offerings into commercial sales through partner channels and service scenarios. It also highlights collaboration with external partners to expand market access, customer conversion, and end-user implementation, which fits a channel-led commercialization strategy. A second strategic thread is the maintenance of apparel SCM services, suggesting a diversified operating base while the healthcare platform scales.
Partner channels shorten the path from product development to sales and improve customer reach.
Linking technical capabilities to service scenarios can improve adoption of biomedical products.
A wider partner network can support scaling beyond internal sales resources.
Geography
The company is headquartered in Hong Kong and files as a foreign private issuer in the United States, indicating a cross-border structure. Recent disclosures reference cooperation tied to the China health and wellness market, so commercial activity appears centered on Greater China with a U.S. capital-market presence. The business also reports a PRC subsidiary structure, which supports operating and commercialization activities in mainland China.
Risks
The business depends on successful commercialization of healthcare and biotech offerings, so execution risk is high if channels do not convert products into recurring sales. It also faces typical China cross-border, regulatory, and partner-dependency risks because growth relies on external service providers, PRC operations, and health-related compliance. The apparel SCM line adds operational complexity and may dilute focus if management resources are split across unrelated businesses.
- Channel partner execution riskImpact: HighLikelihood: High
The sales model relies on third-party channel developers and service operators to reach end customers.
Exposure: Revenue conversion and customer acquisition
- Healthcare regulatory riskImpact: HighLikelihood: Medium
Biotechnology, health products, and medical-related activities are subject to approvals, licensing, and compliance requirements.
Exposure: Product development and market entry
- Cross-border operating riskImpact: MediumLikelihood: High
Hong Kong headquarters, PRC operations, and U.S. listing create legal, tax, and reporting complexity.
Exposure: Corporate compliance and operating continuity
- Business mix complexityImpact: MediumLikelihood: Medium
Apparel SCM and biomedical activities are different operating models and may compete for management attention.
Exposure: Strategic focus and operating efficiency
Accounting
Judgemental itemsReceivables and prepayments require judgment on collectability and recoverability.
Impact: Can materially affect assets and earnings when counterparties underperform
Health products and apparel SCM inventory may require write-downs if demand weakens.
Impact: Affects gross margin and working capital
Commercialization assets and operating facilities may not generate expected returns.
Impact: Can create non-cash charges and reduce equity
Hong Kong and PRC operations create exposure to RMB and other currency movements.
Impact: Impacts accumulated other comprehensive income and equity
Large share changes and deferred stock compensation affect dilution analysis.
Impact: Changes per-share metrics and ownership structure
Similar listed companies
Publicly listed companies with a comparable business focus.
Kun Peng International Ltd.
KPEA · Services-Educational Services
Concord Medical Services Holdings Ltd
CCM · Services-Offices & Clinics of Doctors of Medicine
Concord Medical Services Holdings Ltd is a medical services group headquartered in Beijing, with operations centered on hospital, clinic, and other healthcare service assets in China.
Impact BioMedical, Inc
IBO · Pharmaceutical Preparations
Regencell Bioscience Holdings Ltd
RGC · Medicinal Chemicals & Botanical Products
Regencell Bioscience Holdings Ltd is a Hong Kong-based bioscience company focused on developing botanical and medicinal chemical formulations.
Pitanium Ltd
PTNM · Perfumes, Cosmetics & Other Toilet Preparations
Pitanium Ltd is a Hong Kong-based beauty and personal care retailer that sells proprietary brand products under the PITANIUM and BIG PI names.
Pinnacle Food Group Ltd
PFAI · Agricultural Services
Pinnacle Food Group Ltd is a United States-listed, technology-driven agricultural services company focused on smart agriculture and bio-engineering.
Last updated: 28/09/2026